Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants
A new study combines real-time syndromic surveillance data from daily cross-sectional surveys with a COVID-like illness (CLI) prevalence-based vaccine efficacy estimator to better explain the early onset of the omicron variant.
Source: news-medical.net